Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b

doi:10.3748/wjg.v19.i31.5067

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 31

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6172)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

380

HTML

3308

Figures (1-4)

280

Tables (1-4)

212

Sum=4180

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

970

Download

1022

Sum=1992

Aug 21, 2013 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Aug 21, 2013; 19(31): 5067-5075
Published online Aug 21, 2013. doi: 10.3748/wjg.v19.i31.5067

Table 1 Baseline characteristics of the patients used for screening the biomarkers before initiating chronic hepatitis B therapy (mean ± SE)

	Sustained virological	Non-responders	P value
	responders (n = 9)	(n = 10)
Age (yr)	29.67 ± 8.29	36.90 ± 6.40	0.047
Sex (male:female)	7:2	8:2	0.912
ALT level (U/L)	103.88 ± 105.04	130.50 ± 75.77	0.609
HBV DNA (copies/mL)	(11.07 ± 8.52) × 10⁶	(14.35 ± 8.44) × 10⁶	0.511
HBeAg	Positive	Positive	NS

HBV: Hepatitis B virus; ALT: Alanine aminotransferase; HBeAg: Hepatitis B e antigen; NS: Not significant.

Citation: Kuakarn S, SomParn P, Tangkijvanich P, Mahachai V, Thongboonkerd V, Hirankarn N. Serum proteins in chronic hepatitis B patients treated with peginterferon alfa-2b. World J Gastroenterol 2013; 19(31): 5067-5075
URL: https://www.wjgnet.com/1007-9327/full/v19/i31/5067.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i31.5067